107 related articles for article (PubMed ID: 11051203)
1. Direct transfer of IL-12 gene into growing Renca tumors.
Budryk M; Wilczyńska U; Szary J; Szala S
Acta Biochim Pol; 2000; 47(2):385-91. PubMed ID: 11051203
[TBL] [Abstract][Full Text] [Related]
2. A convenient cancer vaccine therapy with in vivo transfer of interleukin 12 expression plasmid using gene gun technology after priming with irradiated carcinoma cells.
Nishitani MA; Sakai T; Ishii K; Zhang M; Nakano Y; Nitta Y; Miyazaki J; Kanayama HO; Kagawa S; Himeno K
Cancer Gene Ther; 2002 Feb; 9(2):156-63. PubMed ID: 11857033
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy for murine renal cell carcinoma using genetically engineered tumor cells to secrete interleukin-12.
Kasaoka Y; Nakamoto T; Wang J; Usui T; Hamada H
Hiroshima J Med Sci; 2000 Mar; 49(1):29-35. PubMed ID: 10824454
[TBL] [Abstract][Full Text] [Related]
4. Electrotransfer of gene encoding endostatin into normal and neoplastic mouse tissues: inhibition of primary tumor growth and metastatic spread.
Cichoń T; Jamrozy L; Glogowska J; Missol-Kolka E; Szala S
Cancer Gene Ther; 2002 Sep; 9(9):771-7. PubMed ID: 12189527
[TBL] [Abstract][Full Text] [Related]
5. Fusogenic activity of vesicular stomatitis virus glycoprotein plasmid in tumors as an enhancer of IL-12 gene therapy.
Eslahi NK; Muller S; Nguyen L; Wilson E; Thull N; Rolland A; Pericle F
Cancer Gene Ther; 2001 Jan; 8(1):55-62. PubMed ID: 11219494
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effect on murine renal cell carcinoma by autologous tumor vaccines genetically modified with granulocyte-macrophage colony-stimulating factor and interleukin-6 cells.
Kinoshita Y; Kono T; Yasumoto R; Kishimoto T; Wang CY; Haas GP; Nishisaka N
J Immunother; 2001; 24(3):205-11. PubMed ID: 11394497
[TBL] [Abstract][Full Text] [Related]
7. Plasmid DNA gene therapy: studies with the human interleukin-2 gene in tumor cells in vitro and in the murine B16 melanoma model in vivo.
Parker SE; Khatibi S; Margalith M; Anderson D; Yankauckas M; Gromkowski SH; Latimer T; Lew D; Marquet M; Manthorpe M; Hobart P; Hersh E; Stopeck AT; Norman J
Cancer Gene Ther; 1996; 3(3):175-85. PubMed ID: 8725882
[TBL] [Abstract][Full Text] [Related]
8. The use of cationic liposomes DC-CHOL/DOPE and DDAB/DOPE for direct transfer of Escherichia coli cytosine deaminase gene into growing melanoma tumors.
Szala S; Missol E; Sochanik A; Strozyk M
Gene Ther; 1996 Nov; 3(11):1026-31. PubMed ID: 9044744
[TBL] [Abstract][Full Text] [Related]
9. Gene expression and antitumor effects following direct interferon (IFN)-gamma gene transfer with naked plasmid DNA and DC-chol liposome complexes in mice.
Nomura T; Yasuda K; Yamada T; Okamoto S; Mahato RI; Watanabe Y; Takakura Y; Hashida M
Gene Ther; 1999 Jan; 6(1):121-9. PubMed ID: 10341884
[TBL] [Abstract][Full Text] [Related]
10. Combined therapy of B16(F10) murine melanoma using E. coli cytosine deaminase gene and murine interleukin-4 gene.
Missol-Kolka E; Sochanik A; Szala S
Neoplasma; 1998; 45(5):305-11. PubMed ID: 9921920
[TBL] [Abstract][Full Text] [Related]
11. Direct gene transfer to mouse melanoma by intratumor injection of free DNA.
Yang JP; Huang L
Gene Ther; 1996 Jun; 3(6):542-8. PubMed ID: 8789804
[TBL] [Abstract][Full Text] [Related]
12. Tumour therapy with genes encoding apoptin and E4orf4.
Mitrus I; Missol-Kolka E; Plucienniczak A; Szala S
Anticancer Res; 2005; 25(2A):1087-90. PubMed ID: 15868950
[TBL] [Abstract][Full Text] [Related]
13. Effective tumor therapy with plasmid-encoded cytokines combined with in vivo electroporation.
Lohr F; Lo DY; Zaharoff DA; Hu K; Zhang X; Li Y; Zhao Y; Dewhirst MW; Yuan F; Li CY
Cancer Res; 2001 Apr; 61(8):3281-4. PubMed ID: 11309280
[TBL] [Abstract][Full Text] [Related]
14. In vivo growth of transitional and renal cell carcinoma cell lines can be suppressed by the adenovirus-mediated expression of a soluble form of vascular endothelial growth factor receptor.
Ichikura H; Eto M; Ueno H; Harada M; Takayama K; Tokuda N; Tatsugami K; Naito S
Oncol Rep; 2006 May; 15(5):1333-7. PubMed ID: 16596207
[TBL] [Abstract][Full Text] [Related]
15. The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status.
Douin-Echinard V; Bornes S; Rochaix P; Tilkin AF; Peron JM; Bonnet J; Favre G; Couderc B
Cancer Gene Ther; 2000 Dec; 7(12):1543-56. PubMed ID: 11228533
[TBL] [Abstract][Full Text] [Related]
16. In vivo cytokine gene therapy of human tumor xenografts in SCID mice by liposome-mediated DNA delivery.
Egilmez NK; Cuenca R; Yokota SJ; Sorgi F; Bankert RB
Gene Ther; 1996 Jul; 3(7):607-14. PubMed ID: 8818648
[TBL] [Abstract][Full Text] [Related]
17. Neutralization of interleukin-2 retards the growth of mouse renal cancer.
Fukuhara H; Matsumoto A; Kitamura T; Takeuchi T
BJU Int; 2006 Jun; 97(6):1314-21. PubMed ID: 16686731
[TBL] [Abstract][Full Text] [Related]
18. Combination electro-gene therapy using herpes virus thymidine kinase and interleukin-12 expression plasmids is highly efficient against murine carcinomas in vivo.
Goto T; Nishi T; Kobayashi O; Tamura T; Dev SB; Takeshima H; Kochi M; Kuratsu J; Sakata T; Ushio Y
Mol Ther; 2004 Nov; 10(5):929-37. PubMed ID: 15509510
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-21 activates cytotoxic T lymphocytes and natural killer cells to generate antitumor response in mouse renal cell carcinoma.
Kumano M; Hara I; Furukawa J; Oniki S; Nagai H; Miyake H; Fujisawa M
J Urol; 2007 Oct; 178(4 Pt 1):1504-9. PubMed ID: 17707061
[TBL] [Abstract][Full Text] [Related]
20. In vivo transfection of melanoma cells by lithotripter shock waves.
Bao S; Thrall BD; Gies RA; Miller DL
Cancer Res; 1998 Jan; 58(2):219-21. PubMed ID: 9443395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
